Thursday - July 16, 2026
Goodwin Guides Apnimed on Strategic Monetization of Shionogi-Apnimed Sleep Science Joint Venture Stake for $150 Million and Royalties
April 29, 2026
BOSTON, Massachusetts, April 29 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Goodwin Guides Apnimed on Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150 Million and Royalties

*

The Life Sciences team guided Apnimed, Inc. on the sale of its 50% ownership stake in Shionogi-Apnimed Sleep Science, LLC (SASS) to its joint venture partner, Shionogi & Co., Ltd. . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products